Antisense and sensibility

被引:65
作者
Dove, A
机构
关键词
D O I
10.1038/nbt0202-121
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
It took a leap of faith for researchers to believe that antisense technology might lead to novel medicines, but that commitment could soon pay off.
引用
收藏
页码:121 / 124
页数:4
相关论文
共 4 条
[1]   Isis and antisense face crucial test without Novartis [J].
Dove, A .
NATURE BIOTECHNOLOGY, 2000, 18 (01) :19-19
[2]   Analysts: Isis-Lilly deal validates antisense [J].
Niiler, E .
NATURE BIOTECHNOLOGY, 2001, 19 (10) :898-899
[3]  
SAYDA ME, 2001, NATURE, V411, P494
[4]   Peptide nucleic acids targeted to the neurotensin receptor and administered i.p. cross the blood-brain barrier and specifically reduce gene expression [J].
Tyler, BM ;
Jansen, K ;
McCormick, DJ ;
Douglas, CL ;
Boules, M ;
Stewart, JA ;
Zhao, LH ;
Lacy, B ;
Cusack, B ;
Fauq, A ;
Richelson, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (12) :7053-7058